Free Small and IgG-Associated Large Hepatitis B e antigen in the Serum and Glomerular Capillary Walls of Two Patients with Membranous Glomerulonephritis

New England Journal of Medicine

Volumn 300, Issue 15, 1979, Pages 814-819

  Takekoshi, Yasuo ^a,b,c   Tanaka, Masato ^a,b,c   Miyakawa, Yuzo ^a,b,c   Yoshizawa, Hiroshi ^a,b,c   Takahashi, Kazuaki ^a,b,c   Mayumi, Makoto ^a,b,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Jichi Medical School   (United States)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G;

CAPILLARY; CASE REPORT; CYTOLOGY; DIAGNOSIS; GLOMERULUS; HISTOLOGY; KIDNEY; KIDNEY BIOPSY; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; SCHOOL CHILD;

EID: 0018756304     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197904123001502     Document Type: Article

References (43)

1. Churg J, Grishman E, Goldstein MH, et al: Idiopathic nephrotic syndrome in adults: a study and classification based on renal biopsies. N Engl J Med 272: 165–174, 1965
2. Ehrenreich T, Churg J: Pathology of membranous nephropathy. Pathol Annu 3: 145–186, 1968
3. Gluck MC, Gallo G, Lowenstein J, et al: Membranous glomerulonephritis: evolution of clinical and pathologic features. Ann Intern Med 78: 1–12, 1973
4. Koffler D, Agnello V, Thoburn R, et al: Systemic lupus erythematosus: prototype of immune complex nephritis in man. J Exp Med 134: Suppl: 169s–179s, 1971
5. Seegal BC, Andres GA, Hsu KC, et al: Studies on the pathogenesis of acute and progressive glomerulonephritis in man by immunofluorescein and immunoferritin techniques. Fed Proc 24: 100–108, 1965
6. Ward PA, Kibukamusoke JW: Evidence for soluble immune complexes in the pathogenesis of the glomerulonephritis of quartan malaria. Lancet 1: 283–285, 1969
7. Falls WF Jr, Ford KL, Ashworth CT, et al: The nephrotic syndrome in secondary syphilis: report of a case with renal biopsy findings. Ann Intern Med 63: 1047–1058, 1965
8. Naruse T, Kitamura K, Miyakawa Y, et al: Deposition of renal tubular epithelial antigen along the glomerular capillary walls of patients with membranous glomerulonephritis. J Immunol 110: 1163–1166, 1973
9. Miyakawa Y, Kitamura K, Shibata S, et al: Demonstration of human nephritogenic tubular antigen in the serum and organs by radioimmunoassay. J Immunol 117: 1203–1210, 1976
10. Oldstone MBA, Dixon FJ: Immune complex disease in chronic viral infections. J Exp Med 134: Suppl: 32s–40s, 1971
11. Combes B, Stastny P, Shorey J, et al: Glomerulonephritis with deposition of Australia antigen–antibody complexes in glomerular basement membrane. Lancet 2: 234–237, 1971
12. Knieser MR, Jenis EH, Lowenthal DT, et al: Pathogenesis of renal disease associated with viral hepatitis. Arch Pathol 97: 193–200, 1974
13. Kohler PF, Cronin RE, Hammond WS, et al: Chronic membranous glomerulonephritis caused by hepatitis B antigen–antibody complexes. Ann Intern Med 81: 448–451, 1974
14. Bläker F, Hellwege HH, Kramer U, et al: Membranous nephropathy and hepatitis-B antigen. Lancet 2: 955–956, 1974
15. Brzosko WJ, Krawczýnski K, Nazarewicz T, et al: Glomerulonephritis associated with hepatitis-B surface antigen immune complexes in children. Lancet 2: 477–482, 1974
16. Takekoshi Y, Tanaka M, Shida N, et al: Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Lancet 2: 1065–1068, 1978
17. Vyas GN, Shulman NR: Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science 170: 332–333, 1970
18. Imai M, Yamashita Y, Miyakawa Y, et al: Haemagglutination inhibition assay of the common determinants and subspecificities of Australia antigen. Immunology 27: 871–878, 1974
19. Tsuda F, Takahashi T, Takahashi K, et al: Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination. J Immunol 115: 834–838, 1975
20. Takahashi K, Fukuda M, Baba K, et al: Determination of e antigen and antibody to e by means of passive hemagglutination method. J Immunol 119: 1556–1561, 1977
21. Takahashi K, Imai M, Miyakawa Y, et al: Duality of hepatitis B e antigen in serum of persons infected with hepatitis B virus: evidence for the nonidentity of e antigen with immunoglobulins. Proc Natl Acad Sci USA 75: 1952–1956, 1978
22. Yoshizawa H, Itoh Y, Akahane Y, et al: A direct immunofluorescence method for the detection of hepatitis B core antigen in formalin-fixed and gelatin-embedded liver specimens. J Clin Pathol 30: 776–778, 1977
23. Hoofnagle JH, Gerety RJ, Ni LY, et al: Antibody to hepatitis core antigen: a sensitive indicator of hepatitis B virus replication. N Engl J Med 290: 1336–1340, 1974
24. Dane DS, Cameron CH, Briggs M: Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1: 695–698, 1970
25. Almeida JD, Rubenstein D, Stott EJ: New antigen–antibody system in Australia-antigen-positive hepatitis. Lancet 2: 1225–1227, 1971
26. Magnius LO, Espmark JA: New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol 109: 1017–1021, 1972
27. Nielsen JO, Dietrichson O, Juhl E: Incidence and meaning of the “e” determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme. Lancet 1: 913–915, 1974
28. Okdada K, Kamiyama I, Inomata M, et al: e antigen and anti-e in the serum of asymptomatic carrier mothers as indicator of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 294: 746–749, 1976
29. Alter HJ, Seeff LB, Kaplan PM, et al: Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med 295: 909–913, 1976
30. Neurath AR, Strick N: Host specificity of a serum marker for hepatitis B: evidence that “e antigen” has the properties of an immunoglobulin. Proc Natl Acad Sci USA 74: 1702–1706, 1977
31. Fields HA, Bradley DW, Davis DL, et al: Purification and partial characterization of hepatitis e antigen (HBeAg). Infect Immun 20: 792–803, 1978
32. Vyas GN, Peterson DL, Townsend RM, et al: Hepatitis B “e” antigen: an apparent association with lactate dehydrogenase isozyme-5. Science 198: 1068–1070, 1977
33. Neurath AR, Trepo C, Chen M, et al: Identification of additional antigenic sites on Dane particles and the tubular forms of hepatitis B surface antigen. J Gen Virol 30: 277–285, 1976
34. Gerin JL, Shih JW-K, McAuliffe VJ, et al: Antigens of hepatitis B virus: failure to detect HBeAg on the surface of HBsAg forms. J Gen Virol 38: 561–566, 1978
35. Takahashi K, Yamashita S, Imai M, et al: Failure of antibody to e antigen to precipitate Dane particles containing DNA polymerase activity and hepatitis B core antigen. J Gen Virol 38: 431–436, 1978
36. Takahashi K, Akahane Y, Gotanda T, et al: Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol 122: 275–279, 1979
37. Germuth FC, Rodriguez E: lmmunopathology of the Renal Glomerulus. Boston, Little, Brown, 1973
38. Viral hepatitis: the agents (hepatitis B virus). Am J Med Sci 270: 205–209, 1975
39. Gerin JL, Holland PV, Purcell RH: Australia antigen: large scale purification from human serum and biochemical studies on its proteins. J Virol 7: 569–576, 1971
40. Vyas GN, Williams EW, Klaus GGB, et al: Hepatitis-associated Australia antigen: protein, peptides and amino acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol 108: 1114–1118, 1972
41. Aikawa T, Sairenji H, Furuta S, et al: Seroconversion from hepatitis B e antigen to anti-HBe in acute hepatitis B virus infection. N Engl J Med 298: 439–441, 1978
42. Krugman S, Giles JP, Hammond J: Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. J Infect Dis 122: 432–436, 1970
43. Purcell RH, Gerin JL: Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci 270: 395–399, 1975